Brillia Health Cough Control: Homeopathic Product Information

BRILLIA HEALTH COUGH CONTROL- lapine morphine immune globulin, lapine bradykinin immune globulin and lapine histamine immune globulin tablet
Hadaf LLC

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Active Ingredients

Lapine bradykinin immune globulin 12C, 30C, 50C Purpose Reduces frequency and intensity of cough
Lapine morphine immune globulin 12C, 30C, 50C Purpose Reduces pain response
Lapine histamine immune globulin 12C, 30C, 50C Purpose.Reduces histamine and inflammation response

Purpose

Homeopathic,
Reduces frequency and intensity of cough
Reduces pain responseLapine histamine immune
Reduces histamine and inflammation response

Uses

• Suppresses wet and dry cough
• Reduces severity and duration of symptoms, including nasal congestion, cough and sore/itchy throat
• Antihistamine and decongestant/anti-inflammatory
• Reduces sore throat pain

Warnings

Stop use and ask a doctor if symptoms persist or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Allergic (hypersensitivity) reactions may occur in very rare cases.
Do not use if known sensitivity to Brillia Health Cough Control or
any of its ingredients exists.

Stop use

Stop use and ask a doctor if symptoms persist or worsen.

Pregnancy

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Allergies

Allergic (hypersensitivity) reactions may occur in very rare cases.

Do Not Use

Do not use if known sensitivity to Brillia Health Cough Control or
any of its ingredients exists.

Directions

• For adults and children 3 years and older.
• Take orally by holding tablet in the mouth until completely dissolved, without food.
• 1 to 2 tablets 3 times daily.
For severe symptoms, take 4 to 6 times daily for the first 3 days.

Other Information

• Store in original package below 25°C or 77°F. • Do not use if blister pack is torn or broken.

Inactive ingredients

Isomalt, Microcrystalline cellulose, Magnesium stearate, Citric acid (anhydrous), Aspartame, Sodium saccharin.

20 Tablets NDC: 72123-007-01

LABEL 1
(click image for full-size original)
BRILLIA HEALTH COUGH CONTROL lapine bradykinin immune globulin (12c, 30c, 50c), lapine morphine immune globulin (12c, 30c, 50c), lapine histamine immune globulin (12c, 30c, 50c) tablet
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:72123-007
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LAPINE MORPHINE IMMUNE GLOBULIN (LAPINE MORPHINE IMMUNE GLOBULIN) LAPINE MORPHINE IMMUNE GLOBULIN 12 [hp_C]
LAPINE BRADYKININ IMMUNE GLOBULIN (LAPINE BRADYKININ IMMUNE GLOBULIN) LAPINE BRADYKININ IMMUNE GLOBULIN 12 [hp_C]
LAPINE HISTAMINE IMMUNE GLOBULIN (LAPINE HISTAMINE IMMUNE GLOBULIN) LAPINE HISTAMINE IMMUNE GLOBULIN 12 [hp_C]
Inactive Ingredients
Ingredient Name Strength
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
ISOMALT
ANHYDROUS CITRIC ACID
ASPARTAME
SACCHARIN SODIUM
Product Characteristics
Color white Score score with uneven pieces
Shape ROUND Size 9mm
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72123-007-01 2 BLISTER PACK in 1 BOX contains a BLISTER PACK
1 10 TABLET in 1 BLISTER PACK This package is contained within the BOX (72123-007-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved homeopathic 07/31/2020
Labeler — Hadaf LLC (094114708)
Establishment
Name Address ID/FEI Operations
Santonika Uab 520214047 manufacture (72123-007)

Revised: 08/2020 Hadaf LLC

HomeoLabels.com provides trustworthy package insert and label information about marketed homeopathic remedies as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by HomeoLabels.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Main Sections

Homeopathy Information by RSS

We source our database directly from the FDA's central repository of homeopathic remedy labels and package inserts, under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.